img

Global THR- β Agonists Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global THR- β Agonists Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

THR-β (thyroid hormone receptor-beta) agonists are a class of compounds that activate the thyroid hormone receptor-beta, a nuclear receptor involved in regulating gene expression. These agonists bind to the THR-β receptor and stimulate its activity, leading to various physiological effects.
Global THR- β Agonists market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Metabolic Diseases and Cardiovascular Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for THR- β Agonists industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, THR- β Agonists key companies include Madrigal Pharmaceuticals, Terns Pharmaceuticals, Ascletis and Haisco Pharmaceutical Group, etc. Madrigal Pharmaceuticals, Terns Pharmaceuticals, Ascletis are top 3 players and held % share in total in 2022.
THR- β Agonists can be divided into Specification Below 10mg, Specification 10-50mg and Specification Above 50mg,, etc. Specification Below 10mg is the mainstream product in the market, accounting for % share globally in 2022.
THR- β Agonists is widely used in various fields, such as Metabolic Diseases, Cardiovascular Disease and Others,, etc. Metabolic Diseases provides greatest supports to the THR- β Agonists industry development. In 2022, global % share of THR- β Agonists went into Metabolic Diseases filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global THR- β Agonists market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Madrigal Pharmaceuticals
Terns Pharmaceuticals
Ascletis
Haisco Pharmaceutical Group
Segment by Type
Specification Below 10mg
Specification 10-50mg
Specification Above 50mg

Segment by Application


Metabolic Diseases
Cardiovascular Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the THR- β Agonists market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, THR- β Agonists introduction, etc. THR- β Agonists Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of THR- β Agonists market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of THR- β Agonists
1.1 THR- β Agonists Market Overview
1.1.1 THR- β Agonists Product Scope
1.1.2 THR- β Agonists Market Status and Outlook
1.2 Global THR- β Agonists Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global THR- β Agonists Market Size by Region (2018-2033)
1.4 Global THR- β Agonists Historic Market Size by Region (2018-2023)
1.5 Global THR- β Agonists Market Size Forecast by Region (2024-2033)
1.6 Key Regions, THR- β Agonists Market Size (2018-2033)
1.6.1 North America THR- β Agonists Market Size (2018-2033)
1.6.2 Europe THR- β Agonists Market Size (2018-2033)
1.6.3 Asia-Pacific THR- β Agonists Market Size (2018-2033)
1.6.4 Latin America THR- β Agonists Market Size (2018-2033)
1.6.5 Middle East & Africa THR- β Agonists Market Size (2018-2033)
2 THR- β Agonists Market by Type
2.1 Introduction
2.1.1 Specification Below 10mg
2.1.2 Specification 10-50mg
2.1.3 Specification Above 50mg
2.2 Global THR- β Agonists Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global THR- β Agonists Historic Market Size by Type (2018-2023)
2.2.2 Global THR- β Agonists Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America THR- β Agonists Revenue Breakdown by Type (2018-2033)
2.3.2 Europe THR- β Agonists Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific THR- β Agonists Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America THR- β Agonists Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa THR- β Agonists Revenue Breakdown by Type (2018-2033)
3 THR- β Agonists Market Overview by Application
3.1 Introduction
3.1.1 Metabolic Diseases
3.1.2 Cardiovascular Disease
3.1.3 Others
3.2 Global THR- β Agonists Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global THR- β Agonists Historic Market Size by Application (2018-2023)
3.2.2 Global THR- β Agonists Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America THR- β Agonists Revenue Breakdown by Application (2018-2033)
3.3.2 Europe THR- β Agonists Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific THR- β Agonists Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America THR- β Agonists Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa THR- β Agonists Revenue Breakdown by Application (2018-2033)
4 THR- β Agonists Competition Analysis by Players
4.1 Global THR- β Agonists Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in THR- β Agonists as of 2022)
4.3 Date of Key Players Enter into THR- β Agonists Market
4.4 Global Top Players THR- β Agonists Headquarters and Area Served
4.5 Key Players THR- β Agonists Product Solution and Service
4.6 Competitive Status
4.6.1 THR- β Agonists Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Madrigal Pharmaceuticals
5.1.1 Madrigal Pharmaceuticals Profile
5.1.2 Madrigal Pharmaceuticals Main Business
5.1.3 Madrigal Pharmaceuticals THR- β Agonists Products, Services and Solutions
5.1.4 Madrigal Pharmaceuticals THR- β Agonists Revenue (US$ Million) & (2018-2023)
5.1.5 Madrigal Pharmaceuticals Recent Developments
5.2 Terns Pharmaceuticals
5.2.1 Terns Pharmaceuticals Profile
5.2.2 Terns Pharmaceuticals Main Business
5.2.3 Terns Pharmaceuticals THR- β Agonists Products, Services and Solutions
5.2.4 Terns Pharmaceuticals THR- β Agonists Revenue (US$ Million) & (2018-2023)
5.2.5 Terns Pharmaceuticals Recent Developments
5.3 Ascletis
5.3.1 Ascletis Profile
5.3.2 Ascletis Main Business
5.3.3 Ascletis THR- β Agonists Products, Services and Solutions
5.3.4 Ascletis THR- β Agonists Revenue (US$ Million) & (2018-2023)
5.3.5 Haisco Pharmaceutical Group Recent Developments
5.4 Haisco Pharmaceutical Group
5.4.1 Haisco Pharmaceutical Group Profile
5.4.2 Haisco Pharmaceutical Group Main Business
5.4.3 Haisco Pharmaceutical Group THR- β Agonists Products, Services and Solutions
5.4.4 Haisco Pharmaceutical Group THR- β Agonists Revenue (US$ Million) & (2018-2023)
5.4.5 Haisco Pharmaceutical Group Recent Developments
6 North America
6.1 North America THR- β Agonists Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe THR- β Agonists Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific THR- β Agonists Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America THR- β Agonists Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa THR- β Agonists Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 THR- β Agonists Market Dynamics
11.1 THR- β Agonists Industry Trends
11.2 THR- β Agonists Market Drivers
11.3 THR- β Agonists Market Challenges
11.4 THR- β Agonists Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market THR- β Agonists Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global THR- β Agonists Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global THR- β Agonists Market Size Share by Region (2018-2023)
Table 4. Global THR- β Agonists Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global THR- β Agonists Forecasted Market Size Share by Region (2024-2033)
Table 6. Global THR- β Agonists Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global THR- β Agonists Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global THR- β Agonists Revenue Market Share by Type (2018-2023)
Table 9. Global THR- β Agonists Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global THR- β Agonists Revenue Market Share by Type (2024-2033)
Table 11. North America THR- β Agonists Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America THR- β Agonists Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe THR- β Agonists Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe THR- β Agonists Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific THR- β Agonists Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific THR- β Agonists Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America THR- β Agonists Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America THR- β Agonists Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa THR- β Agonists Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa THR- β Agonists Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global THR- β Agonists Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global THR- β Agonists Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global THR- β Agonists Revenue Market Share by Application (2018-2023)
Table 24. Global THR- β Agonists Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global THR- β Agonists Revenue Market Share by Application (2024-2033)
Table 26. North America THR- β Agonists Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America THR- β Agonists Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe THR- β Agonists Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe THR- β Agonists Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific THR- β Agonists Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific THR- β Agonists Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America THR- β Agonists Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America THR- β Agonists Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa THR- β Agonists Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa THR- β Agonists Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global THR- β Agonists Revenue (US$ Million) by Players (2018-2023)
Table 37. Global THR- β Agonists Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in THR- β Agonists as of 2022)
Table 39. Date of Key Players Enter into THR- β Agonists Market
Table 40. Global THR- β Agonists Key Players Headquarters and Area Served
Table 41. THR- β Agonists Product Solution and Service
Table 42. Global THR- β Agonists Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Madrigal Pharmaceuticals Basic Information List
Table 45. Madrigal Pharmaceuticals Description and Business Overview
Table 46. Madrigal Pharmaceuticals THR- β Agonists Products, Services and Solutions
Table 47. Revenue (US$ Million) in THR- β Agonists Business of Madrigal Pharmaceuticals (2018-2023)
Table 48. Madrigal Pharmaceuticals Recent Developments
Table 49. Terns Pharmaceuticals Basic Information List
Table 50. Terns Pharmaceuticals Description and Business Overview
Table 51. Terns Pharmaceuticals THR- β Agonists Products, Services and Solutions
Table 52. Revenue (US$ Million) in THR- β Agonists Business of Terns Pharmaceuticals (2018-2023)
Table 53. Terns Pharmaceuticals Recent Developments
Table 54. Ascletis Basic Information List
Table 55. Ascletis Description and Business Overview
Table 56. Ascletis THR- β Agonists Products, Services and Solutions
Table 57. Revenue (US$ Million) in THR- β Agonists Business of Ascletis (2018-2023)
Table 58. Ascletis Recent Developments
Table 59. Haisco Pharmaceutical Group Basic Information List
Table 60. Haisco Pharmaceutical Group Description and Business Overview
Table 61. Haisco Pharmaceutical Group THR- β Agonists Products, Services and Solutions
Table 62. Revenue (US$ Million) in THR- β Agonists Business of Haisco Pharmaceutical Group (2018-2023)
Table 63. Haisco Pharmaceutical Group Recent Developments
Table 64. North America THR- β Agonists Market Size by Country (2018-2023) & (US$ Million)
Table 65. North America THR- β Agonists Market Size by Country (2024-2033) & (US$ Million)
Table 66. Europe THR- β Agonists Market Size by Country (2018-2023) & (US$ Million)
Table 67. Europe THR- β Agonists Market Size by Country (2024-2033) & (US$ Million)
Table 68. Asia-Pacific THR- β Agonists Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 69. Asia-Pacific THR- β Agonists Market Size by Region (2018-2023) & (US$ Million)
Table 70. Asia-Pacific THR- β Agonists Market Size by Region (2024-2033) & (US$ Million)
Table 71. Asia-Pacific THR- β Agonists Market Share by Region (2018-2023)
Table 72. Asia-Pacific THR- β Agonists Market Share by Region (2024-2033)
Table 73. Latin America THR- β Agonists Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 74. Latin America THR- β Agonists Market Size by Country (2018-2023) & (US$ Million)
Table 75. Latin America THR- β Agonists Market Size by Country (2024-2033) & (US$ Million)
Table 76. Middle East & Africa THR- β Agonists Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 77. Middle East & Africa THR- β Agonists Market Size by Country (2018-2023) & (US$ Million)
Table 78. Middle East & Africa THR- β Agonists Market Size by Country (2024-2033) & (US$ Million)
Table 79. THR- β Agonists Market Trends
Table 80. THR- β Agonists Market Drivers
Table 81. THR- β Agonists Market Challenges
Table 82. THR- β Agonists Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global THR- β Agonists Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global THR- β Agonists Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global THR- β Agonists Market Share by Regions: 2022 VS 2033
Figure 4. Global THR- β Agonists Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America THR- β Agonists Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe THR- β Agonists Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific THR- β Agonists Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America THR- β Agonists Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa THR- β Agonists Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Specification Below 10mg
Figure 11. Global Specification Below 10mg Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Specification 10-50mg
Figure 13. Global Specification 10-50mg Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Specification Above 50mg
Figure 15. Global Specification Above 50mg Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Global THR- β Agonists Market Size Share by Type: 2022 & 2033
Figure 17. North America THR- β Agonists Revenue Market Share by Type (2018-2033)
Figure 18. Europe THR- β Agonists Revenue Market Share by Type (2018-2033)
Figure 19. Asia-Pacific THR- β Agonists Revenue Market Share by Type (2018-2033)
Figure 20. Latin America THR- β Agonists Revenue Market Share by Type (2018-2033)
Figure 21. Middle East and Africa THR- β Agonists Revenue Market Share by Type (2018-2033)
Figure 22. Metabolic Diseases Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Cardiovascular Disease Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Global THR- β Agonists Market Size Share by Application: 2022 & 2033
Figure 26. North America THR- β Agonists Revenue Market Share by Application (2018-2033)
Figure 27. Europe THR- β Agonists Revenue Market Share by Application (2018-2033)
Figure 28. Asia-Pacific THR- β Agonists Revenue Market Share by Application (2018-2033)
Figure 29. Latin America THR- β Agonists Revenue Market Share by Application (2018-2033)
Figure 30. Middle East and Africa THR- β Agonists Revenue Market Share by Application (2018-2033)
Figure 31. THR- β Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 32. Global Top 5 and Top 10 Players THR- β Agonists Market Share in 2022
Figure 33. North America THR- β Agonists Market Share by Country (2018-2033)
Figure 34. United States THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 35. Canada THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 36. Germany THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 37. France THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 38. U.K. THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 39. Italy THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 40. Russia THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 41. Nordic Countries THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 42. Asia-Pacific THR- β Agonists Market Share by Region (2018-2033)
Figure 43. China THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 44. Japan THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 45. South Korea THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 46. Southeast Asia THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 47. India THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 48. Australia THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 49. Latin America THR- β Agonists Market Share by Country (2018-2033)
Figure 50. Mexico THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 51. Brazil THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 52. Middle East & Africa THR- β Agonists Market Share by Country (2018-2033)
Figure 53. Turkey THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 55. UAE THR- β Agonists Market Size (2018-2033) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries